PTPN11 and myelodysplastic syndrome: SHP2 variants are also present in some other blood cancers, such as myelodysplastic syndrome (10%) and B cell acute lymphoblastic leukemia myelodysplastic syndrome (10%), and seldomly in solid tumors (Kanumuri et al., 2022).